SZSE:301096 (China)
Â
Class A
Â¥
63.73
(+5.03%)
Jun 21
Business Description
Hangzhou Bio-Sincerity Pharma-Tech Co Ltd
ISIN : CNE1000056N5
Share Class Description:
SZSE:301096: Class ACompare
Compare
Traded in other countries / regions
301096.China IPO Date
2021-12-20Description
Hangzhou Bio-Sincerity Pharma-Tech Co Ltd is a pharmaceutical technology research and development company. The company's business covers drug discovery, pharmaceutical research, clinical research, and registration application.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.24 | |||||
Equity-to-Asset | 0.72 | |||||
Debt-to-Equity | 0.23 | |||||
Debt-to-EBITDA | 2.02 | |||||
Interest Coverage | 86.67 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 4.57 | |||||
Beneish M-Score | -1.49 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 54.2 | |||||
3-Year EBITDA Growth Rate | 51.7 | |||||
3-Year EPS without NRI Growth Rate | 48.4 | |||||
3-Year FCF Growth Rate | -30.5 | |||||
3-Year Book Growth Rate | 80.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 74.91 | |||||
9-Day RSI | 61.77 | |||||
14-Day RSI | 53.71 | |||||
6-1 Month Momentum % | 0.98 | |||||
12-1 Month Momentum % | 4.37 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.73 | |||||
Quick Ratio | 1.6 | |||||
Cash Ratio | 0.82 | |||||
Days Inventory | 94.48 | |||||
Days Sales Outstanding | 69.98 | |||||
Days Payable | 236.43 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.49 | |||||
Dividend Payout Ratio | 0.28 | |||||
Forward Dividend Yield % | 0.49 | |||||
5-Year Yield-on-Cost % | 0.49 | |||||
3-Year Average Share Buyback Ratio | -10.3 | |||||
Shareholder Yield % | -4.24 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 66.04 | |||||
Operating Margin % | 29.79 | |||||
Net Margin % | 26.74 | |||||
FCF Margin % | -70.02 | |||||
ROE % | 10.94 | |||||
ROA % | 8.17 | |||||
ROIC % | 12.8 | |||||
ROC (Joel Greenblatt) % | 20.06 | |||||
ROCE % | 11.34 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 24.05 | |||||
PE Ratio without NRI | 22.46 | |||||
PEG Ratio | 0.42 | |||||
PS Ratio | 6.42 | |||||
PB Ratio | 2.53 | |||||
Price-to-Tangible-Book | 2.62 | |||||
EV-to-EBIT | 20.52 | |||||
EV-to-EBITDA | 20.52 | |||||
EV-to-Revenue | 6.03 | |||||
EV-to-FCF | -8.56 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.07 | |||||
Price-to-Graham-Number | 1.62 | |||||
Price-to-Net-Current-Asset-Value | 12.05 | |||||
Earnings Yield (Greenblatt) % | 4.87 | |||||
FCF Yield % | -10.82 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hangzhou Bio-Sincerity Pharma-Tech Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 1,072.23 | ||
EPS (TTM) (Â¥) | 2.65 | ||
Beta | 0 | ||
Volatility % | 27.47 | ||
14-Day RSI | 53.71 | ||
14-Day ATR (Â¥) | 2.157839 | ||
20-Day SMA (Â¥) | 61.308 | ||
12-1 Month Momentum % | 4.37 | ||
52-Week Range (Â¥) | 51.01 - 77.78 | ||
Shares Outstanding (Mil) | 108.92 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Hangzhou Bio-Sincerity Pharma-Tech Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Hangzhou Bio-Sincerity Pharma-Tech Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Hangzhou Bio-Sincerity Pharma-Tech Co Ltd Frequently Asked Questions
What is Hangzhou Bio-Sincerity Pharma-Tech Co Ltd(SZSE:301096)'s stock price today?
The current price of SZSE:301096 is ¥63.73. The 52 week high of SZSE:301096 is ¥77.78 and 52 week low is ¥51.01.
When is next earnings date of Hangzhou Bio-Sincerity Pharma-Tech Co Ltd(SZSE:301096)?
The next earnings date of Hangzhou Bio-Sincerity Pharma-Tech Co Ltd(SZSE:301096) is .
Does Hangzhou Bio-Sincerity Pharma-Tech Co Ltd(SZSE:301096) pay dividends? If so, how much?
The Dividend Yield %  of Hangzhou Bio-Sincerity Pharma-Tech Co Ltd(SZSE:301096) is 0.49% (As of Today), Highest Dividend Payout Ratio of Hangzhou Bio-Sincerity Pharma-Tech Co Ltd(SZSE:301096) was 0.38. The lowest was 0.28. And the median was 0.36. The  Forward Dividend Yield % of Hangzhou Bio-Sincerity Pharma-Tech Co Ltd(SZSE:301096) is 0.49%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |